Leuko

About:

Leuko Labs develops non-invasive white blood cell monitoring device.

Website: https://leuko.com

Twitter/X: leuko

Top Investors: National Cancer Institute, Good Growth Capital, IAG Capital Partners, MassVentures, Nina Capital

Description:

Leuko Labs develops non-invasive white blood cell monitoring device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Though its white blood cell monitoring device PointCheck, immunosuppressed patients can now be tested more frequently, moving towards improved quality of life and improved clinical outcomes.